Celltrion is transitioning from biosimilar excellence to next-generation innovative therapeutics with plans to expand manufacturing and R&D capabilities in the U.S. to support long-term growth and enhance supply resilience. Following a record year in 2025, Celltrion has entered a full-scale growth phase, targeting consolidated revenue of KRW 5.3 trillion in 2026.
Cyborg Score Rationale
In 2024, Celltrion's revenue was 3.56 trillion, an increase of 63.45% compared to the previous year's 2.18 trillion. The company demonstrates strong fundamentals with rapid growth and strategic expansion into innovative therapies beyond biosimilars. Margin improvement initiatives and aggressive revenue targeting support operational momentum.
Top Insights
Five products transitioning into full-year sales cycles in 2026 with COGS ratio improving to 35.8% in Q4 2025, down from 63% in Q4 2023
Recent strategic moves include a 100.4 billion won CDMO deal with TEVA and acquisition of iQone Healthcare Switzerland for European expansion
Developing next-generation therapeutics including antibody-drug conjugates (ADCs) and multi-specific antibodies (msAbs) with clinical pipeline at advanced stages
Founder Seo Jung-jin is the richest person in South Korea, indicating strong insider commitment and governance stability
Named Competitors
Samsung Biologics — Biopharmaceutical CDMO and biosimilar developer
Sandoz — Leading global biosimilar manufacturer
Amgen Biosimilars — Major biosimilar portfolio
Pfizer Biosimilars — Large-scale biosimilar production
Recent Developments
(January 2026) Unveiled strategic priorities for innovative drug pipelines including ADCs and msAbs at J.P. Morgan Healthcare Conference
(August 2025) Bid $504.3 million for Eli Lilly's BB50 Branchburg, NJ manufacturing site
(November 2024) Acquired iQone Healthcare Switzerland for European expansion
(October 2024) Secured 100.4 billion won CDMO contract with TEVA for migraine treatment
Open the full interactive Celltrion, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.